1. Home
  2. FATE vs NNBR Comparison

FATE vs NNBR Comparison

Compare FATE & NNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • NNBR
  • Stock Information
  • Founded
  • FATE 2007
  • NNBR 1980
  • Country
  • FATE United States
  • NNBR United States
  • Employees
  • FATE N/A
  • NNBR N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • NNBR Industrial Machinery/Components
  • Sector
  • FATE Health Care
  • NNBR Industrials
  • Exchange
  • FATE Nasdaq
  • NNBR Nasdaq
  • Market Cap
  • FATE 116.5M
  • NNBR 109.1M
  • IPO Year
  • FATE 2013
  • NNBR 1994
  • Fundamental
  • Price
  • FATE $1.47
  • NNBR $1.75
  • Analyst Decision
  • FATE Hold
  • NNBR
  • Analyst Count
  • FATE 6
  • NNBR 0
  • Target Price
  • FATE $3.30
  • NNBR N/A
  • AVG Volume (30 Days)
  • FATE 3.1M
  • NNBR 109.4K
  • Earning Date
  • FATE 11-11-2025
  • NNBR 10-29-2025
  • Dividend Yield
  • FATE N/A
  • NNBR N/A
  • EPS Growth
  • FATE N/A
  • NNBR N/A
  • EPS
  • FATE N/A
  • NNBR N/A
  • Revenue
  • FATE $8,470,000.00
  • NNBR $433,709,000.00
  • Revenue This Year
  • FATE N/A
  • NNBR N/A
  • Revenue Next Year
  • FATE N/A
  • NNBR $4.88
  • P/E Ratio
  • FATE N/A
  • NNBR N/A
  • Revenue Growth
  • FATE N/A
  • NNBR N/A
  • 52 Week Low
  • FATE $0.66
  • NNBR $1.58
  • 52 Week High
  • FATE $3.50
  • NNBR $4.67
  • Technical
  • Relative Strength Index (RSI)
  • FATE 62.81
  • NNBR 28.43
  • Support Level
  • FATE $1.30
  • NNBR $1.81
  • Resistance Level
  • FATE $1.65
  • NNBR $1.99
  • Average True Range (ATR)
  • FATE 0.17
  • NNBR 0.12
  • MACD
  • FATE 0.02
  • NNBR -0.02
  • Stochastic Oscillator
  • FATE 73.77
  • NNBR 4.89

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About NNBR NN Inc.

NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.

Share on Social Networks: